Related Experiment Video
Updated: May 26, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
Trachoma and antibiotic use: the 'A' in SAFE
1Wilmer RM 129, Johns Hopkins University, 600 N Wolfe Street, Baltimore, MD 21205, USA. shwest@jhmi.edu
Abstract:
Trachoma, a chronic conjunctivitis caused by Chlamydia trachomatis, is the leading infectious cause of blindness worldwide. In recognition of this public health problem, the World Health Assembly has targeted the year 2020 to eliminate blinding trachoma, and a multifaceted strategy (SAFE) is recommended, including antibiotics for treatment of infection. Trachoma is a disease of entire communities, and the pool of infection resides largely in preschool age children. Thus, for endemic communities, mass treatment with antibiotics annually for at least 3-5 years is carried out. The antibiotics used, the effectiveness of this approach, and the challenges of antibiotic treatment of communities are discussed, concluding with a view towards the elimination of trachoma in the future.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Acne Infection
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Inhibitors of Bacterial Protein Synthesis
Sexually Transmitted Infections

